A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 26, 2002

Primary Completion Date

May 17, 2004

Study Completion Date

May 17, 2004

Conditions
Infection, Human Immunodeficiency Virus IHIV Infection
Interventions
DRUG

abacavir/lamivudine

DRUG

abacavir

DRUG

lamivudine

Trial Locations (56)

925

GSK Investigational Site, Rio Piedras

10011

GSK Investigational Site, New York

10014

GSK Investigational Site, New York

10019

GSK Investigational Site, New York

11794

GSK Investigational Site, Stony Brook

17033

GSK Investigational Site, Hershey

19601

GSK Investigational Site, Reading

20007

GSK Investigational Site, Washington D.C.

20009

GSK Investigational Site, Washington D.C.

21201

GSK Investigational Site, Baltimore

23666

GSK Investigational Site, Hampton

27710

GSK Investigational Site, Durham

27858

GSK Investigational Site, Greenville

28209

GSK Investigational Site, Charlotte

30033

GSK Investigational Site, Decatur

30308

GSK Investigational Site, Atlanta

30339

GSK Investigational Site, Atlanta

30912

GSK Investigational Site, Augusta

32206

GSK Investigational Site, Jacksonville

32804

GSK Investigational Site, Orlando

32806

GSK Investigational Site, Orlando

33133

GSK Investigational Site, Miami

33136

GSK Investigational Site, Miami

33145

GSK Investigational Site, Fort Lauderdale

33308

GSK Investigational Site, Fort Lauderdale

33316

GSK Investigational Site, Fort Lauderdale

33317

GSK Investigational Site, Plantation

33602

GSK Investigational Site, Tampa

33614

GSK Investigational Site, Tampa

33901

GSK Investigational Site, Fort Myers

37916

GSK Investigational Site, Knoxville

44304

GSK Investigational Site, Akron

67214

GSK Investigational Site, Wichita

74127

GSK Investigational Site, Tulsa

75204

GSK Investigational Site, Dallas

75208

GSK Investigational Site, Dallas

75219

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

77004

GSK Investigational Site, Houston

77027

GSK Investigational Site, Houston

80205

GSK Investigational Site, Denver

80220

GSK Investigational Site, Denver

85006

GSK Investigational Site, Phoenix

90028

GSK Investigational Site, Los Angeles

90033

GSK Investigational Site, Los Angeles

90502

GSK Investigational Site, Torrance

90813

GSK Investigational Site, Long Beach

92708

GSK Investigational Site, Fountain Valley

95825

GSK Investigational Site, Sacramento

94115-1931

GSK Investigational Site, San Francisco

08844

GSK Investigational Site, Hillsborough

08244

GSK Investigational Site, Somers Point

29206-4713

GSK Investigational Site, Columbia

Unknown

GSK Investigational Site, San José

GSK Investigational Site, Panama City

00731

GSK Investigational Site, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ViiV Healthcare

INDUSTRY